ABD - İngilizce - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium have been reported [see warnings and precautions ( 5.4)] . the use of 10 ml cisatracurium multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml - dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. dexmedetomidine injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine injection has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine injection prior to extubation. dexmedetomidine injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none. pregnancy category c there are no adequate and well-controlled studies of dexmedetomidine use in pregnant women. in an in vitro human placenta study, placental transfer of dexmedetomidine occurred. in a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously. thus, fetal exposure should be expected in human

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu jiangsu sincere pharmaceutical co., ltd - menthol  2.0%, methyl salicylate  2.0% - menthol                    topical analgesic methyl salicylate       topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: simple backache arthritis sprains strains bruises on wounds or damaged skin. with other external analgesic products at the same time. if you are allergic to any ingredients of this product. otherwise than as directed. avoid contact with the eyes, mucous membranes or rashes.

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu gold worldworks household chemicals co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 ml in 100 ml - purpose antiseptic uses antiseptic use for hand washing to decrease bacteria on the skin

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu lingyun pharmaceutical co., ltd - toltrazuril (unii: qvz3iar3js) (toltrazuril - unii:qvz3iar3js) - toltrazuril 1 kg in 1 kg

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu hengrui pharmaceuticals co., ltd. - docetaxel (unii: 15h5577cqd) (docetaxel anhydrous - unii:699121phca) - docetaxel anhydrous 20 mg in 1 ml - docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. docetaxel injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. docetaxel injection in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition. docetaxel injection in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer. docetaxel injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced ga

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium have been reported [see warnings and precautions ( 5.4)] . the use of 10 ml cisatracurium multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jiangsu agrochem laboratory co ltd - butafenacil; triasulfuron - water dispersible granule - butafenacil pyrimidine active 200.0 g/kg; triasulfuron urea-sulfonyl active 520.0 g/kg - herbicide

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

mentholatum australasia pty ltd - 37697 - compress, hot pack, chemical - provides heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, strains, sprains and arthritis. it is intended to increase blood flow to promote muscle pain and tension relief. this product is air activated and is disposable.

ABD - İngilizce - NLM (National Library of Medicine)

jiangsu xinheyuan plastic daily chemical co., ltd. - triclosan (unii: 4nm5039y5x) (triclosan - unii:4nm5039y5x) - antibacterial for washing to decrease bacteria on the skin. if irritation and redness develops.